基于基因功能的创新药物研究

ChineseBulletinofLifeSciences17420058Vol.17,No.4Aug.,20052012032005-08-052004CB5189012005BA711A04(1963)(1980)(1965)(1945)*1004-0374(2005)04-0288-06[1]212121()11.120Novartis2080Bcr-AblGleevec(STI571)[2]STI571Bcr-AblSTI571Millennium10002(ACE-2)289ACE-2I[3](HMG-CoA-2)()2003SARSSARS[4~8]()()()()(SystemsBiology)(druggability)[9~12](highcontentscreening,HCS)[13~14](→→→→)(highthroughputscreening,HTS)60GDNA50%6020Ras/MAPKPI-3K/AKTJAK/STAT2129010I~III[15~16]606%~10%(/)[17]()(20105000)[18~19]60%1/33/4(1)(2)(3)(JAK/STAT)1.21998~200397380973()22.12911/101/5()2.2(HCS)HCSHCS(largescalecellbiology)HCSHTSHCS2.3(specificityandse-lectivity)()33.1111229211/(HTS/HCS)()HTS/HCS12123.23.2.1()(1)(2)(3)(4)ADME/T()()()(5)(6)3.2.2()2()(HTS)(HCS)()(ADME/T)()(G)RNA1A6(domain)siRNA2()HTS/HCS(PD)(AD)PDα-Parkinα-Parkinα-I(complexI)α-PDA2A293α-A2APDAβ()APPτAPPτHTS()HCSADAD(HIVgp41HBVcapsids)HTSHCS4[1][2]BuchdungerE,ZimmermannJ,MettH,etal.Inhibitionoftheablprotein-tyrosinekinaseinvitroandinvivobya2-phenylaminopyrimidinederivative.CancerRes,1996,56:100~104[3]DonoghueM,HsiehF,BaronasE,etal.Anovelangiotensin-convertingenzyme-relatedcarboxypeptidase(ACE2)con-vertsangiotensinItoangiotensin1~9.CircRes,2000,87:E1~E9[4]MarraMA,JonesSJM,AstellCR,etal.TheGenomesequenceoftheSARS-associatedcoronavirus.Science,2003,300:1399~1404[5]RotaPA,ObersteMS,MonroeSS,etal.Characterizationofanovelcoronavirusassociatedwithsevereacuterespira-torysyndrome.Science,2003,300:1394~1399[6]QinZQ,WangJ,LiW.Acompletesequenceandcompara-tiveanalysisofaSARS-associatedvirus(IsolateBJ01).ChinSciBull,2003,48:941~948[7]StadlerK,MasignaniV,EickmannM,etal.SARS-beginningtounderstandanewvirus.NatRevMicrobiol,2003,1:209~218[8]LuoC,LuoHB,ZhengSX,etal.NucleocapsidproteinofSARScoronavirustightlybindstohumancyclophilinA.BiochemBiophysResCommun,2004,321:557~565[9]IdekerT,GalitskiT,HoodL.Anewapproachtodecodinglife:systemsbiology.AnnuRevGenomicsHumGenet,2001,2:343~372[10]KitanoH.Systemsbiology:abriefoverview.Science,2002,95:1662~1664[11]BonettaL.SystemsbiologythenewR&Dbuzzword.NatMed,2002,8:315~316[12]IshiiN,RobertM,NakayamaY,etal.Towardlarge-scalemodelingofthemicrobialcellforcomputersimulation.JBiotechnol,2004,113:281~294[13]LiptrotC.Highcontentscreeningfromcellstodatatoknowledge.DrugDiscovToday,2001,6:832~834[14]EdwardsBS,OpreaT,ProssnitzER,etal.Flowcytometryforhigh-throughput,high-contentscreening.CurrOpinChemBiol,2004,8:392~398[15]DuffaudF,BlayJY.Gastrointestinalstromaltumors:biol-ogyandtreatment.Oncology,2003,65:187~197[16]GiacconeG,HerbstRS,ManegoldC,etal.Gefitinibincombinationwithgemcitabineandcisplatininadvancednon-small-celllungcancer:aphaseIIItrial-intact1.JClinOncol,2004,22:777~784[17],..,2005,40:251~254[18]AlbertiKG,ZimmetPZ.Definition,diagnosisandclassifi-cationofdiabetesmellitusanditscomplications.Part1:diagnosisandclassificationofdiabetesmellitusprovisionalreportofaWHOconsultation.DiabetMed,1998,15:539~553[19]ScheenAJ.Managementofthemetabolicsyndrome.MinervaEndocrinol,2004,29:31~45